All News #Library
Others
IDT Bolsters CRISPR Portfolio with SeQure Dx Licensing Deal
24 Jul 2024 //
CONTRACT PHARMA
IDT And SeQure Dx Sign Licensing Agreement For CRISPR Therapeutics
15 Jul 2024 //
BUSINESSWIRE

Market Place
Sourcing Support